Seethal A. Jacob, MD - Pediatric Hematology - Oncology

Seethal A. Jacob, MD

Pediatric Hematology - Oncology

Employed Provider

Accepting Pediatric Patients

317.944.2143 Refer a Patient

Dr. Seethal A. Jacob specializes in Pediatric Hematology-Oncology for Riley Pediatric Cancer & Blood Disorders. Dr. Jacob earned her undergraduate degree at the University of Notre Dame before earning her medical degree at Wright State University, Boonshoft School of Medicine, Fairborn, OH. She then completed a residency at Indiana University School of Medicine and a fellowship at the University of Pittsburgh School of Medicine.

Dr. Jacob's primary location is Riley Pediatric Cancer & Blood Disorders, 575 Riley Hospital Dr., Indianapolis, IN 46202. In addition to English, she speaks Malay.

Riley Pediatric Cancer & Blood Disorders photo Riley Pediatric Cancer & Blood Disorders

575 Riley Hospital Dr.

Hematology/Oncology MSA

Indianapolis, IN, 46202

Get Directions 317.944.2143
Riley Children's Sickle Cell Program photo Riley Children's Sickle Cell Program

705 Riley Hospital Drive

Suite 2600

Indianapolis, IN, 46202

Get Directions 317.944.2143
Specialties
  • Pediatric Hematology - Oncology
Education
  • Undergraduate: University of Notre Dame
  • Masters degree: University of Pittsburgh
  • School of Medicine: Wright State University, Boonshoft School of Medicine, Fairborn, OH
  • Residency: Indiana University School of Medicine, Indianapolis, IN
  • Fellowship: University of Pittsburgh School of Medicine, Pittsburgh, PA
Hospitals & Affiliations
  • IU Health Medical Group
  • Riley Physicians
  • Aetna Medicare Advantage
  • Anthem Blue Cross Blue Shield
  • Anthem Healthy Indiana Plan
  • Anthem Hoosier Care Connect
  • Anthem Hoosier Healthwise
  • Anthem Indiana PathWays for Aging
  • Anthem Medicare Advantage HMO
  • Anthem Medicare Advantage PPO
  • Anthem Pathway Essentials Network
  • CareSource Healthy Indiana Plan
  • CareSource Hoosier Healthwise
  • CareSource Marketplace
  • Cigna HealthCare HMO
  • Cigna HealthCare PPO
  • Cigna Marketplace
  • Community Health Network Employee Plan
  • Encore Combined
  • Encore Elite
  • Encore Workers Compensation
  • Health Alliance Medicare Advantage
  • Humana Healthy Horizons Indiana PathWays for Aging
  • Humana Medicare Advantage HMO
  • Humana Medicare Advantage PFFS
  • Humana Medicare Advantage PPO
  • Indiana University Workers Compensation
  • Indiana University Health Workers Compensation
  • Managed Health Services Healthy Indiana Plan
  • Managed Health Services Hoosier Care Connect
  • Managed Health Services Hoosier Healthwise
  • Managed Health Services Marketplace
  • Managed Health Services Medicare Advantage (Allwell)
  • Point Comfort Unaccompanied Children Program
  • United HealthCare Community Plan Indiana PathWays for Aging
  • United HealthCare Hoosier Care Connect
  • United HealthCare Marketplace
  • United HealthCare Medicare Advantage D-SNP
  • United HealthCare Medicare Advantage HMO
  • United HealthCare Medicare Advantage POS
  • United HealthCare Medicare Advantage PPO
  • Zing Health Medicare Advantage C-SNP
  • Zing Health Medicare Advantage D-SNP
  • Zing Health Medicare Advantage HMO
  • Zing Health Medicare Advantage POS
  • Zing Health Medicare Advantage PPO

Note: Although this listing was accurate at the time of posting, insurances change regularly, and insurance plans listed may not be accepted at all office locations for this provider. Please confirm with your insurance company that this provider is covered by your plan before your appointment.

Explore the ongoing clinical trials this provider is involved in and learn about the eligibility requirements for each one. Search the clinical trial directory to find additional clinical trials.

Telemedicine for Pediatric Sickle Cell Patients in Medically Underserved Areas

View Details

GRNDaD

View Details

Use of Point-of-Care Ultrasound (POCUS) for the Diagnosis of Acute Chest Syndrome in Patients with Sickle Cell Disease

View Details
Search All Clinical Trials
View more about “Next-generation therapy” for blood disorders at Riley
“Next-generation therapy” for blood disorders at Riley

A 12-year-old Greenwood girl is the first patient to undergo the gene therapy approved for thalassemia and sickle cell disease.

Read the Story
View more about Five things to know about sickle cell disease
Five things to know about sickle cell disease

Dr. Seethal Jacob, director of the Comprehensive Pediatric Sickle Cell Program at Riley Hospital, shares info on the blood disorder as we close out Sickle Cell Awareness Month.

Read the Story